Table 1 Characteristics of the patients included in the psychometric validation study
Characteristics | N = 307 |
|---|---|
Gender, n (%) | |
Female | 203 (66.1%) |
Age (years), mean (SD) | 65.1 (12.5) |
range | 23.0–94.0 |
Personal situation, n (%) | |
Living alone at home | 58 (18.9%) |
Living with other at home | 248 (80.8%) |
Living in assisted living environment | 1 (0.3%) |
Other | 0 (0.0%) |
Education, n (%) | |
CGSE/O level | 97 (31.6%) |
A Level or equivalent | 60 (19.5%) |
Undergraduate degree | 36 (11.7%) |
Post-graduate | 31 (10.1%) |
Other | 83 (27.0%) |
Professional status, n (%) | |
Full time paid employment | 61 (19.9%) |
Part time work | 43 (14.0%) |
Homemaker/housewife | 17 (5.5%) |
Student | 1 (0.3%) |
Unemployed | 4 (1.3%) |
Retired | 171 (55.7%) |
Other | 10 (3.3%) |
Time from diagnosis to questionnaire completion (years), mean (SD) | 12.3 (9.8) |
range | 0.5–56.7 |
Use of at least one RA treatment other than MTX, n (%) | |
Yes | 220 (71.7%) |
No | 87 (28.3%) |
Presence of comorbidities, n (%) | |
Yes | 133 (43.3%) |
No | 174 (56.7%) |
Time between first dose of MTX and questionnaire completion, n (%) | |
Less than a year | 6 (2.0%) |
From 1 to less than 5 years | 94 (30.6%) |
From 5 to less than 10 years | 99 (32.2%) |
10 years or more | 108 (35.2%) |
Weekly MTX dosage (mg), mean (SD) | 15.7 (5.4) |
range | 5.0–30.0 |
6-month PDC < 80%, n(%) | 89 (29.0%) |
12-month PDC < 80%, n(%) | 85 (27.7%) |
ACCEPT General Acceptance Score, mean (SD) | 74.2 (27.5) |
range | 0.0–100 |
RAPID-3 Total Score, mean (SD) | 9.3 (5.9) |
range | 0.0–25.7 |